ESC Congress 2023 Introduction
At the ESC Congress 2023 (25-28 August, Amsterdam, The Netherlands) novel findings were revealed in more than 3,750 abstracts and clinical cases presented by scientists from 86 countries. Here we highlight latest insights on targeting atherogenic lipoproteins, likely mediators of effects seen in REDUCE-IT, genetic causal links between remnant cholesterol and cardiovascular outcomes, elevated TG […]
Read More > ESC Congress 2023 Introduction